{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T12:07:28Z","timestamp":1687435648839},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T00:00:00Z","timestamp":1401926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00108-014-3523-9","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T11:49:34Z","timestamp":1403783374000},"page":"859-862","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neue antihyperglyk\u00e4mische Therapeutika"],"prefix":"10.1007","volume":"55","author":[{"given":"B.","family":"Gallwitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nitschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,5]]},"reference":[{"key":"3523_CR1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1479164112465442","volume":"10","author":"Forst","year":"2013","unstructured":"Forst T, Hanefeld M, Jacob S et al (2013) Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies. Diab Vasc Dis Res 10:302\u2013314","journal-title":"Diab Vasc Dis Res"},{"key":"3523_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","volume":"367","author":"ORIGIN","year":"2012","unstructured":"ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR et al (2012) Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 367:319\u2013328","journal-title":"N Engl J Med"},{"key":"3523_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1479164112475102","volume":"10","author":"Rosenstock","year":"2013","unstructured":"Rosenstock J, Marx N, Kahn SE et al (2013) Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial. Diab Vasc Dis Res 10:289\u2013301","journal-title":"Diab Vasc Dis Res"},{"key":"3523_CR4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","volume":"369","author":"Scirica","year":"2013","unstructured":"Scirica BM, Bhatt DL, Braunwald E et al (2013) Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 369:1317\u20131326","journal-title":"N Engl J Med"},{"key":"3523_CR5","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","volume":"369","author":"White","year":"2013","unstructured":"White WB, Cannon CP, Heller SR et al (2013) Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 369:1327\u20131335","journal-title":"N Engl J Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-014-3523-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-014-3523-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-014-3523-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:17:39Z","timestamp":1558585059000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-014-3523-9"}},"subtitle":["Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care (EXAMINE) und Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus \u2013 Thrombolysis in Myocardial Infarction (SAVOR-TIMI\u00a053)"],"short-title":[],"issued":{"date-parts":[[2014,6,5]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["3523"],"URL":"https:\/\/doi.org\/10.1007\/s00108-014-3523-9","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,5]]}}}